Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

ENTAMOEBA SP - ANVISA Registration 80254180250

Access comprehensive regulatory information for ENTAMOEBA SP in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80254180250 and manufactured by REMEL EUROPE LIMITED. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including R-BIOPHARM AG, ACRO BIOTECH, INC. (MONTCLAIR), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80254180250
Registration Details
ANVISA Registration Number: 80254180250
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

PROSPECT ENTAMOEBA HISTOLYTICA KIT
Risk Class II

Registration Details

80254180250

25351151390201704

04930429000139

Company Information

England (United Kingdom)
PT: INGLATERRA (REINO UNIDO)

Dates and Status

Apr 24, 2017

VIGENTE

09/18/2025 19:00:01